Scott Wolchko
Board Member
Fate Therapeutics Inc (FATE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Scott Wolchko
Scott Wolchko is recorded as CEO and Board Member at Fate Therapeutics Inc (FATE). The proxy statement of Fate Therapeutics Inc reports total compensation of $4,175,069 for Scott Wolchko in fiscal 2024, including a base salary of $675,000. Disclosed compensation is on record for 8 fiscal years. Scott Wolchko has spoken on 17 earnings calls across 1 company, most recently for Fate Therapeutics Inc on May 9, 2024.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Fate Therapeutics Inc
Other people whose current roles at this company are on record from its filings.
- Bahram Valamehr CEO, Board Member
- William H. Rastetter Chairman
- J. Scott Wolchko CFO, Chief Accounting Officer
- Kamal Adawi CFO, Chief Accounting Officer
- Cindy R. Tahl General Counsel
- Edward J. Dulac III Chief Accounting Officer
- Karin Jooss Board Member
- Karin Jooss, Ph.D. Board Member
- Laura J. Hamill Board Member
- Matthew Abernethy Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Fate Therapeutics Inc (FATE) | CEO | $675,000 | $4,175,069 |
| 2023 | Fate Therapeutics Inc (FATE) | CEO | $645,000 | $3,522,750 |
| 2022 | Fate Therapeutics Inc (FATE) | CEO | $645,000 | $8,145,000 |
| 2021 | Fate Therapeutics Inc (FATE) | CEO | $610,000 | $11,728,617 |
| 2020 | Fate Therapeutics Inc (FATE) | CEO | $570,000 | $5,600,167 |
| 2019 | Fate Therapeutics Inc (FATE) | CEO | $540,000 | $10,720,955 |
| 2018 | Fate Therapeutics Inc (FATE) | CEO | $516,000 | $3,530,998 |
| 2017 | Fate Therapeutics Inc (FATE) | CEO | $480,000 | $1,304,789 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.